Understanding how glioblastoma tumors use fat for growth
Identifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolism
This study is looking at how a protein called SREBP-1 helps aggressive brain tumors called glioblastomas grow, with the hope of finding new treatment options for patients battling this tough condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10773033 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the activation of a protein called SREBP-1 in glioblastoma, a highly aggressive brain tumor. By exploring how glioblastoma cells manipulate lipid metabolism, the study aims to uncover new strategies for treatment. The researchers will examine the molecular pathways that allow these cancer cells to thrive, particularly focusing on the role of glutamine in SREBP-1 activation. This could lead to innovative therapeutic approaches for patients suffering from this challenging condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with glioblastoma, particularly those who are 21 years or older.
Not a fit: Patients with other types of brain tumors or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that specifically target the metabolic processes of glioblastoma, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in targeting metabolic pathways in cancer, suggesting that this approach could be effective for glioblastoma as well.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Guo, Deliang — Ohio State University
- Study coordinator: Guo, Deliang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.